Refine
Has Fulltext
- yes (11)
Is part of the Bibliography
- yes (11)
Document Type
- Journal article (11)
Language
- English (11)
Keywords
- multiple myeloma (2)
- somatic mutations (2)
- ATG7 (1)
- Background Epithelioid haemangioma (1)
- CXCR4 (1)
- Hodgkin lymphoma (1)
- IL-17 (1)
- Lipom (1)
- MTCH2 (1)
- Medizin (1)
- PET (1)
- T(H)17 cells (1)
- [\(^{68}\)Ga] pentixafor (1)
- adhesion (1)
- apoptosis (1)
- autophagy (1)
- cancer genomics (1)
- disease (1)
- gene expression (1)
- growth patterns (1)
- haematological cancer (1)
- helper T cells (1)
- lineage (1)
- lymphocytes (1)
- lymphoid tissues (1)
- mast cells (1)
- metastasis (1)
- myasthenia gravis (1)
- myeloma (1)
- oncology (1)
- p53 (1)
- pancreatic cancer (1)
- pathway (1)
- pleural mesothelioma (1)
- protein kinase pathway (1)
- receptor tyrosine kinases (1)
- relapse (1)
- targeted (1)
- theranostics (1)
- thymic carcinoma (1)
- thymoma (1)
- thymus (1)
- tumor microenvironment (1)
- up regulation (1)
- whole-exome sequencing (1)
Institute
- Pathologisches Institut (9)
- Medizinische Klinik und Poliklinik II (3)
- Comprehensive Cancer Center Mainfranken (2)
- Klinik und Poliklinik für Dermatologie, Venerologie und Allergologie (1)
- Klinik und Poliklinik für Nuklearmedizin (1)
- Lehrstuhl für Orthopädie (1)
- Medizinische Klinik und Poliklinik I (1)
- Theodor-Boveri-Institut für Biowissenschaften (1)
Burkitt lymphoma (BL) is the most common B-cell lymphoma in children. Within the International Cancer Genome Consortium (ICGC), we performed whole genome and transcriptome sequencing of 39 sporadic BL. Here, we unravel interaction of structural, mutational, and transcriptional changes, which contribute to MYC oncogene dysregulation together with the pathognomonic IG-MYC translocation. Moreover, by mapping IGH translocation breakpoints, we provide evidence that the precursor of at least a subset of BL is a B-cell poised to express IGHA. We describe the landscape of mutations, structural variants, and mutational processes, and identified a series of driver genes in the pathogenesis of BL, which can be targeted by various mechanisms, including IG-non MYC translocations, germline and somatic mutations, fusion transcripts, and alternative splicing.